Akèy › Rabdomiyosakòm › Massachusetts › Boston
Etid klinik pou Rabdomiyosakòm nan Boston, MA
4 etid pou Rabdomiyosakòm ap chèche patisipan nan sit nan ak bò kote Boston (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)
Ap rekriteFaz 3
- Dana-Farber Cancer Institute, Boston
PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors
Ap rekriteFaz 1/2
- Boston Children's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
VITAS: Atezolizumab in Combination With Chemotherapy for Pediatric Relapsed/Refractory Solid Tumors
Ap rekriteFaz 1/2
- Boston Children's Hospital, Boston
Phase 1/2 Trial to Evaluate the Safety and Efficacy of PEEL-224 in Combination With Vincristine and Temozolomide in Adolescents and Young Adults With Relapsed or Refractory Sarcomas
Ap rekriteFaz 1/2
- Boston Children's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
- Brigham and Women's Hospital, Boston
Etid Rabdomiyosakòm nan lòt vil
- Houston, TX6 etid
- Memphis, TN6 etid
- Washington, DC5 etid
- Salt Lake City, UT4 etid
- Philadelphia, PA4 etid
- Seattle, WA3 etid
- Aurora, CO3 etid
- Dallas, TX3 etid
- Birmingham, AL3 etid
- The Bronx, NY3 etid
- Baltimore, MD3 etid
Lòt etid nan Boston
- Kansè nan tete111 etid
- Kansè Poumon ki pa ti selil90 etid
- Kansè (tout kalite)86 etid
- Kansè kolorektal63 etid
- Kansè Metastatik63 etid
- Kansè poumon62 etid
- Kansè ovè61 etid
- Kansè pwostat59 etid
- Depresyon52 etid
- Kansè Endomèt50 etid
- Ensifizyans kadyak44 etid
- Leksemi mieloïd egi44 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.